Breast Cancer Liver Metastasis: Primary tumor predictors and histopathologic characteristics of metastatic lesions.
In a human observational cohort of 47 patients with breast cancer liver metastases, the study reports enrichment for young-onset and recent-postpartum disease, frequent ER-positive replacement-pattern metastases, and histologic findings consistent with use of existing liver sinusoids.
Open original publication →What the AI sees
In a human observational cohort of 47 patients with breast cancer liver metastases, the study reports enrichment for young-onset and recent-postpartum disease, frequent ER-positive replacement-pattern metastases, and histologic findings consistent with use of existing liver sinusoids.
Research significance
The evidence supports associations among young or postpartum status, luminal breast cancer, and liver metastasis characteristics; it only suggests—not demonstrates—that postpartum liver biology or sinusoid-dependent replacement growth could eventually inform risk stratification or provide therapeutic targets.
Source abstract
Young breast cancer patients have increased risk for liver metastasis (BCLM), implicating age-dependent organotropism. To explore potential risk factors and mechanisms of BCLM, we unbiasedly recruited 47 patients diagnosed with BCLM at a tertiary medical center, collected clinicopathologic data of the primary breast cancers, and obtained paired BCLM lesion tissue. Compared to the overall breast cancer patient population, our BCLM cohort was enriched ~4 fold for young patients (YOBC) and ~5 fold for patients diagnosed within 10 years of recent childbirth. The majority of primary breast cancer diagnoses were luminal A, low-grade and early-stage disease, clinical attributes classically associated with good prognosis. Most BCLM lesions were also ER-positive, and the dominant breast cancer growth pattern was replacement. Immunohistology staining infers utilization of existing liver sinusoids, consistent with a passive mechanism of metastatic invasion. In sum, these data suggest that the liver readily supports metastatic establishment of early-stage, luminal A breast cancer cells. These data also support a growing body of literature linking postpartum liver biology to increased risk for BCLM, providing potential insight into the observed age-dependent organotropism of BCLM. Improved understanding of reproductive risk factors for BCLM may improve patient risk stratification and outcomes overall.